ATE176913T1 - Faser-hemagglutinin von b. pertussis - Google Patents
Faser-hemagglutinin von b. pertussisInfo
- Publication number
- ATE176913T1 ATE176913T1 AT89912578T AT89912578T ATE176913T1 AT E176913 T1 ATE176913 T1 AT E176913T1 AT 89912578 T AT89912578 T AT 89912578T AT 89912578 T AT89912578 T AT 89912578T AT E176913 T1 ATE176913 T1 AT E176913T1
- Authority
- AT
- Austria
- Prior art keywords
- pertussis
- hemagglutinin
- therapy
- fiber
- filamentous hemagglutinin
- Prior art date
Links
- 241000588832 Bordetella pertussis Species 0.000 title abstract 2
- 101710154606 Hemagglutinin Proteins 0.000 title 1
- 101710093908 Outer capsid protein VP4 Proteins 0.000 title 1
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 title 1
- 101710176177 Protein A56 Proteins 0.000 title 1
- 239000000835 fiber Substances 0.000 title 1
- 239000000185 hemagglutinin Substances 0.000 title 1
- 101710154643 Filamentous hemagglutinin Proteins 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 238000002560 therapeutic procedure Methods 0.000 abstract 2
- 108091005461 Nucleic proteins Proteins 0.000 abstract 1
- 108700026244 Open Reading Frames Proteins 0.000 abstract 1
- 201000005702 Pertussis Diseases 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
- C12N9/127—RNA-directed RNA polymerase (2.7.7.48), i.e. RNA replicase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Rotary Switch, Piano Key Switch, And Lever Switch (AREA)
- Insulated Conductors (AREA)
- Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26364888A | 1988-10-27 | 1988-10-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE176913T1 true ATE176913T1 (de) | 1999-03-15 |
Family
ID=23002666
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT89912578T ATE176913T1 (de) | 1988-10-27 | 1989-10-20 | Faser-hemagglutinin von b. pertussis |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0439542B1 (de) |
| JP (1) | JPH04501506A (de) |
| AT (1) | ATE176913T1 (de) |
| AU (1) | AU643190B2 (de) |
| CA (1) | CA1341123C (de) |
| DE (1) | DE68928933T2 (de) |
| DK (1) | DK76191A (de) |
| FI (1) | FI911973A0 (de) |
| WO (1) | WO1990004641A1 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5643753A (en) | 1990-04-18 | 1997-07-01 | Connaught Laboratories Limited | Use of autologous promoters to express gene products in bordetella |
| GB9008746D0 (en) * | 1990-04-18 | 1990-06-13 | Connaught Lab | The use of autologous promoters to express gene products in bordetella |
| DE4111531A1 (de) * | 1991-04-09 | 1992-10-29 | Biotechnolog Forschung Gmbh | Plasmide zur fha-expression und wirte |
| WO1994021816A1 (en) * | 1993-03-25 | 1994-09-29 | Envirocon International Incorporated | Test kits and methods for rapidly testing for contamination by microorganisms |
| US5646251A (en) * | 1993-11-05 | 1997-07-08 | The Board Of Trustees Of Leeland Stanford Jr. Univ. | Alloreaction-associated antigen (ARAG): a novel member of the immunoglobulin gene superfamily |
| FR2718750B1 (fr) * | 1994-04-19 | 1996-06-14 | Pasteur Institut | Protéines recombinantes de l'hémagglutinine filamenteuse de Bordetella, notamment, B. Pertussis, production et application à la production de protéines étrangères ou de principes actifs vaccinants. |
| EP1069133A1 (de) | 1999-07-13 | 2001-01-17 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Neisseria meningitidis Zusammensetzungen und ihre Verwendungen als anti-infektionsmitteln |
| ITMI20090946A1 (it) | 2009-05-28 | 2010-11-29 | Novartis Ag | Espressione di proteine ricombinanti |
| US8916173B2 (en) | 2013-03-08 | 2014-12-23 | Crucell Holland B.V. | Acellular pertussis vaccine |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6176422A (ja) * | 1984-09-22 | 1986-04-18 | Chemo Sero Therapeut Res Inst | 百日ぜきコンポ−ネントワクチンおよび百日ぜき・ジフテリア・破傷風混合ワクチンの製造方法 |
| FR2590483B1 (fr) * | 1985-11-22 | 1988-12-09 | Pasteur Institut | Antigenes purifies ayant des proprietes vaccinantes contre b. pertussis, moyens notamment adns recombinants pour les produire et compositions de vaccins les contenant |
| GB8601279D0 (en) * | 1986-01-20 | 1986-02-26 | Public Health Lab Service | Purification of pertussis antigens |
| CA1337859C (en) * | 1987-04-24 | 1996-01-02 | Masashi Chazono | Method for culturing bordetella pertussis, a pertussis toxoid and a pertussis vaccine |
-
1989
- 1989-09-29 CA CA000614474A patent/CA1341123C/en not_active Expired - Fee Related
- 1989-10-20 DE DE68928933T patent/DE68928933T2/de not_active Expired - Fee Related
- 1989-10-20 WO PCT/US1989/004732 patent/WO1990004641A1/en active IP Right Grant
- 1989-10-20 AU AU45155/89A patent/AU643190B2/en not_active Ceased
- 1989-10-20 AT AT89912578T patent/ATE176913T1/de not_active IP Right Cessation
- 1989-10-20 EP EP89912578A patent/EP0439542B1/de not_active Expired - Lifetime
- 1989-10-20 JP JP1511783A patent/JPH04501506A/ja active Pending
-
1991
- 1991-04-23 FI FI911973A patent/FI911973A0/fi unknown
- 1991-04-25 DK DK076191A patent/DK76191A/da unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0439542A4 (en) | 1991-11-06 |
| JPH04501506A (ja) | 1992-03-19 |
| WO1990004641A1 (en) | 1990-05-03 |
| AU643190B2 (en) | 1993-11-11 |
| DK76191D0 (da) | 1991-04-25 |
| EP0439542A1 (de) | 1991-08-07 |
| DE68928933D1 (de) | 1999-04-01 |
| CA1341123C (en) | 2000-10-17 |
| EP0439542B1 (de) | 1999-02-24 |
| DE68928933T2 (de) | 1999-08-26 |
| FI911973A0 (fi) | 1991-04-23 |
| AU4515589A (en) | 1990-05-14 |
| DK76191A (da) | 1991-06-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE9002522L (sv) | Metod foer framstaellning av en farmaceutisk komposition i form av mikropartiklar | |
| IT8224948A0 (it) | Virus vaccinico modificato e metodi per la produzione ed uso del medesimo. | |
| DK0835133T3 (da) | Rekombinant koppevirus-rabies-præparater og kombinationspræparater samt anvendelser deraf | |
| DE3485267D1 (de) | Herstellung von streptokokken-m-protein-immunogenen und molekularen sonden. | |
| IT8819077A0 (it) | Processo per la preparazione di 1,2 difluoroetano e di 1,1,2trifluoroetano. | |
| ES2109254T3 (es) | Proteinas antigenas y vacunas que las contienen para la prevencion de cocidiosis. | |
| NO912825D0 (no) | Fremgangsmaate for fremstilling av cokonjugate vaksiner omfattende immunogenisk protein, hiv-beslektede peptider og anioniske grupper. | |
| NO904471D0 (no) | Fremgangsmaate for fremstilling av partikkelformig titandioxyd. | |
| DK0909323T3 (da) | Helicobacter pylori-bakterioferritin | |
| ATE176913T1 (de) | Faser-hemagglutinin von b. pertussis | |
| DK163062C (da) | Antigen, immunogen, proteinholdig vaccine imod coccidiose | |
| DE3854387D1 (de) | Einschlusskomplex von Nicardipin oder seinem Hydrochlorid mit beta-Cyclodextrin, ein Verfahren zur Herstellung desselben und eine diesen enthaltende pharmazeutische Zubereitung mit verzögerter Wirkung. | |
| DE68922042D1 (de) | Verfahren zur Herstellung von Titanoxid. | |
| DE69017608D1 (de) | Verfahren für die Bestimmung von Distickstoffoxid. | |
| SE8902148D0 (sv) | Syntetiska peptid antigen foer detektion av htlv-1 infektion | |
| DE68914042D1 (de) | Verfahren zur Herstellung von Polyfluorokohlenwasserstoffiodid. | |
| DE69021761D1 (de) | Impfstoff gegen Tinea. | |
| DE68912734D1 (de) | Verfahren zur Herstellung von Tetrafluoräthylen. | |
| HU9200583D0 (en) | Method for producing el peptides of rubeola | |
| DE68912809D1 (de) | Verfahren zur Herstellung von Bis(2,2,6,6-tetramethyl-4-piperidyl)amin. | |
| DE69013621D1 (de) | Verfahren zur Herstellung von tertiärem Amino-Alkohol. | |
| DE58905605D1 (de) | Verfahren zur Herstellung von cyclischen Harnstoffen. | |
| IT8049346A0 (it) | Composizione antigene relativo vaccino e procedimento di produzione | |
| NO912823D0 (no) | Fremgangsmaate for fremstilling av klasse ii-proteinet av neisseria meningitidis samt vaksiner som inneholder dette. | |
| DE3686684D1 (de) | Mittel zur absorptionsverbesserung von proteinen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |